|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||


*
Laboratory of Immunology, National Institute of Allergy and Infectious Diseases,
Laboratory of Diagnostic Radiology Research, and
Neuroimmunology Branch, National Institute of Neurological Diseases and Stroke, National Institutes of Health, Bethesda, MD 20892;
§
Department of Neurology, University of California, San Francisco, CA 94143; and
¶
Alexion Pharmaceuticals, New Haven, CT 06511
Definition of the immune process that causes demyelination in multiple sclerosis is essential to determine the feasibility of Ag-directed immunotherapy. Using the nonhuman primate, Callithrix jacchus jacchus (common marmoset), we show that immunization with myelin basic protein and proteolipid protein determinants results in clinical disease with significant demyelination. Demyelination was associated with spreading to myelin oligodendrocyte glycoprotein (MOG) determinants that generated anti-MOG serum Abs and Ig deposition in central nervous system white matter lesions. These data associate intermolecular "determinant spreading" with clinical autoimmune disease in primates and raise important issues for the pathogenesis and treatment of multiple sclerosis.
This article has been cited by other articles:
![]() |
Y. S. Kap, P. Smith, S. A. Jagessar, E. Remarque, E. Blezer, G. J. Strijkers, J. D. Laman, R. Q. Hintzen, J. Bauer, H. P. M. Brok, et al. Fast Progression of Recombinant Human Myelin/Oligodendrocyte Glycoprotein (MOG)-Induced Experimental Autoimmune Encephalomyelitis in Marmosets Is Associated with the Activation of MOG34-56-Specific Cytotoxic T Cells J. Immunol., February 1, 2008; 180(3): 1326 - 1337. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Berger, P. Rubner, F. Schautzer, R. Egg, H. Ulmer, I. Mayringer, E. Dilitz, F. Deisenhammer, and M. Reindl Antimyelin Antibodies as a Predictor of Clinically Definite Multiple Sclerosis after a First Demyelinating Event N. Engl. J. Med., July 10, 2003; 349(2): 139 - 145. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P. M. Brok, M. van Meurs, E. Blezer, A. Schantz, D. Peritt, G. Treacy, J. D. Laman, J. Bauer, and B. A. 't Hart Prevention of Experimental Autoimmune Encephalomyelitis in Common Marmosets Using an Anti-IL-12p40 Monoclonal Antibody J. Immunol., December 1, 2002; 169(11): 6554 - 6563. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F. de Vos, M. van Meurs, H. P. Brok, L. A. Boven, R. Q. Hintzen, P. van der Valk, R. Ravid, S. Rensing, L. Boon, B. A. 't Hart, et al. Transfer of Central Nervous System Autoantigens and Presentation in Secondary Lymphoid Organs J. Immunol., November 15, 2002; 169(10): 5415 - 5423. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Cavacini, M. Duval, J. P. Eder, and M. R. Posner Evidence of Determinant Spreading in the Antibody Responses to Prostate Cell Surface Antigens in Patients Immunized with Prostate-specific Antigen Clin. Cancer Res., February 1, 2002; 8(2): 368 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Brooks-Worrell, V. H. Gersuk, C. Greenbaum, and J. P. Palmer Intermolecular Antigen Spreading Occurs During the Preclinical Period of Human Type 1 Diabetes J. Immunol., April 15, 2001; 166(8): 5265 - 5270. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. P.M. Brok, A. Uccelli, N. Kerlero de Rosbo, R. E. Bontrop, L. Roccatagliata, N. G. de Groot, E. Capello, J. D. Laman, K. Nicolay, G.-L. Mancardi, et al. Myelin/Oligodendrocyte Glycoprotein-Induced Autoimmune Encephalomyelitis in Common Marmosets: The Encephalitogenic T Cell Epitope pMOG24-36 Is Presented by a Monomorphic MHC Class II Molecule J. Immunol., July 15, 2000; 165(2): 1093 - 1101. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |